Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • Bitcoin USD

    64,343.74
    +1,045.75 (+1.65%)
     

  • CMC Crypto 200

    1,382.47
    +69.85 (+5.32%)
     

  • S&P 500

    4,966.27
    -44.85 (-0.89%)
     

  • Dow

    37,962.57
    +187.19 (+0.50%)
     

  • Nasdaq

    15,279.70
    -321.80 (-2.06%)
     

  • Gold

    2,409.10
    +11.10 (+0.46%)
     

  • Crude Oil

    83.24
    +0.51 (+0.62%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. :T14-SG: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017

CapitalCube
Updated
Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. :T14-SG: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017

Categories: Yahoo FinanceGet free summary analysis Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of USD 207.21 million, Net Earnings of USD 10.71 million. Gross margins widened from 23.87% to 34.51% compared to the same period last year, operating (EBITDA) margins now 0.97% from ... Read more (Read more...)

Continue reading